These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9469627)

  • 21. Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.
    Chong AY; Chin BS; Blann AD; Lip GY
    Thromb Res; 2005; 116(2):181-3. PubMed ID: 15907534
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithrombotic therapy for congestive heart failure.
    Chung I; Lip GY
    Int J Clin Pract; 2006 Jan; 60(1):36-47. PubMed ID: 16409427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation abnormalities in patients undergoing myocardial revascularization.
    Zajtchuk R; Collins GJ; Schuchmann GF; Holley PW; Hamaker WR
    J Thorac Cardiovasc Surg; 1978 Feb; 75(2):168-70. PubMed ID: 304943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostatic abnormalities associated with cancer and its therapy.
    Glassman AB
    Ann Clin Lab Sci; 1997; 27(6):391-5. PubMed ID: 9433535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemostasis and thrombosis in critically ill children.
    Kenet G; Strauss T; Kaplinsky C; Paret G
    Semin Thromb Hemost; 2008 Jul; 34(5):451-8. PubMed ID: 18956285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
    Lip GY; Chung I
    Thromb Res; 2005; 116(4):275-7. PubMed ID: 16038710
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and treatment of coagulation disorders].
    Esnaola-Rojas MM
    Rev Neurol; 1999 Dec 16-31; 29(12):1290-300. PubMed ID: 10652759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelets and heart failure.
    Chung I; Lip GY
    Eur Heart J; 2006 Nov; 27(22):2623-31. PubMed ID: 17028108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?
    Katz SD
    J Cardiovasc Risk; 1995 Apr; 2(2):97-102. PubMed ID: 7606657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet function, thrombin and fibrinolytic activity in patients with heart failure.
    Jafri SM; Ozawa T; Mammen E; Levine TB; Johnson C; Goldstein S
    Eur Heart J; 1993 Feb; 14(2):205-12. PubMed ID: 8449196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y; Ohmori T; Hoshide S; Madoiwa S; Yamamoto K; Katsuki T; Mitsuhashi T; Mimuro J; Shimada K; Kario K; Sakata Y
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation.
    Ponce R; Armstrong K; Andrews K; Hensler J; Waggie K; Heffernan J; Reynolds T; Rogge M
    Toxicol Pathol; 2005; 33(6):702-10. PubMed ID: 16243775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure.
    Sbarouni E; Bradshaw A; Andreotti F; Tuddenham E; Oakley CM; Cleland JG
    Am Heart J; 1994 Mar; 127(3):607-12. PubMed ID: 8122609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse effects of glucocorticoids: coagulopathy.
    Coelho MC; Santos CV; Vieira Neto L; Gadelha MR
    Eur J Endocrinol; 2015 Oct; 173(4):M11-21. PubMed ID: 25971647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation factors in nephrotic syndrome.
    Kanfer A
    Am J Nephrol; 1990; 10 Suppl 1():63-8. PubMed ID: 2256477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
    Lip GY; Gibbs CR
    J Am Coll Cardiol; 1999 Apr; 33(5):1424-6. PubMed ID: 10193748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The coagulation system changes in patients with chronic heart failure.
    Mongirdiene A; Kursvietiene L; Kasauskas A
    Medicina (Kaunas); 2010; 46(9):642-7. PubMed ID: 21252600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.